Scholarly publications and presentations by Rochester Regional Health's Internal Medicine department authors.

Follow


Submissions from 2026

Link

4-1-2026          Lupus podocytopathy: A systematic review of clinical evidence from cases and cohorts, Qi Wang, Bismah Basharat, Kefang Sun, Rochester Regional Health, et al.

Link

4-1-2026          Post-myocardial infarction complications in patients with inflammatory bowel disease: a retrospective cohort study using the National Inpatient Sample (2016-2022), Omar Alkasabrah, Siddharth Pravin Agrawal, Abdullah Hafeez, et al.

Link

4-1-2026          Prospective quasi-experimental study on 3D-printed model-assisted patient counseling in women's reproductive health, Dima Saleh, Rochester Regional Health, Noha A. Mousa, Haya Ibrahim, et al.

Link

4-1-2026          Reply: Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF, Mahmoud Eisa, Rochester Regional Health, Hossam Elbenawi, Abhishek J. Deshmukh, et al.

Link

4-1-2026          Secondary Hemophagocytic Lymphohistiocytosis as the Initial Presentation of Metastatic Carcinoma of Likely Colorectal Origin, Kavya Balusu, Rochester Regional Health, Ali Abdelhay, Rochester Regional Health, Kim Sung Eun, Rochester Regional Health, et al.

Link

4-1-2026          Unprovoked Venous Thromboembolism in a Patient with a Small PNH Clone: A Therapeutic Dilemma, Kavya Balusu, Rochester Regional Health; Dhatri Malipeddi, Rochester Regional Health; and Pradyumna Phatak, Rochester Regional Health

Link

3-15-2026          BRAF Mutations in Myeloid Neoplasms: Prevalence, Co-Mutation Landscape, and Clinical Outcomes-A Comprehensive Review., Shehab F. Mohamed, Ali S. Mohamed, Rochester Regional Health, Mohamed Fawzi Mudarres, et al.

Link

3-13-2026          Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes of prostate cancer patients receiving gonadotropin-releasing hormone agonists, Zhiting Tang, Rochester Regional Health, Yu-Cheng Chang, Kuan-Yu Chi, et al.

Link

3-1-2026          Clinical evaluation and bone loss prediction of titanium-zirconium implants: A retrospective study of 1-5-year follow-up, Zhaoting Ling, Cong Chen, Siyuan Wang, et al.

Link

3-1-2026          Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials, Ayah Abulehia, Hazem Ayesh, Omar Ayesh, et al.

Link

3-1-2026          Gastrointestinal Toxicities of Targeted Cancer Therapies: A Narrative Review, Eunice K. Omeludike, Uchechukwu N. Oguama, Nneoma Ubah, et al.

Link

3-1-2026          Glucagon-Like Peptide-1 Receptor Agonists for Bile Acid Diarrhea: Emerging Evidence and Clinical Implications, Eunice K. Omeludike, Cherechi O. Nwabueze, Nneoma Ubah, et al.

Link

3-1-2026          Impact of Optimizing the Lower Limit of Normal for Ferritin on Iron Deficiency Diagnosis and Treatment Patterns: A Pre and Post-Intervention Study Using EHR Data, Ali Abdelhay, Rochester Regional Health, Mouna Reghis, Rochester Regional Health, Tamer Salhab Altamimi, Rochester Regional Health, et al.

Link

3-1-2026          Isolated nonparathyroid hormone-mediated hypercalcemia: a rare presentation of retroperitoneal sarcoidosis, Chao Xue, Rochester Regional Health, Ranjini Vengilote, Rochester Regional Health, Astrid Michelle Aviles Melendez, Rochester Regional Health, et al.

Link

3-1-2026          Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement Among Patients With Prior Mediastinal Radiation, Hossam Elbenawi, Mahmoud Eisa, Rochester Regional Health, Muhammad Eltony, et al.

Link

3-1-2026          Machine Learning for Predicting Colorectal Cancer and Advanced Colorectal Polyps: A Systematic Review and Meta-Analysis, Sheza Malik, Rochester Regional Health, Arsalan Naqvi, Bettina G. Tenorio, et al.

Link

3-1-2026          Multigland dysfunction from immune-checkpoint inhibitors: a case of hypothyroidism, diabetes, and adrenal insufficiency, Ranjini Vengilote, Rochester Regional Health, Oyiyechukwu Onwudiwe, Rochester Regional Health, Alshaima Yousef, Rochester Regional Health, et al.

Link

3-1-2026          Racial disparities and trends in the in-hospital mortality for malignant prostate cancer, Jugraj Singh, Shahzeb Saeed, Ayushi Garg, et al.

Link

2-10-2026          Hypercalcaemia as an immune-related adverse event secondary to ipilimumab and nivolumab therapy in a patient with metastatic renal cell carcinoma, Hala Osman, Rochester Regional Health; Aditya Sanjeevi, Rochester Regional Health; and Chao-Yu Hsu, Rochester Regional Health

Link

2-3-2026          Gestational Diabetes Diagnosed Early in Pregnancy: Effects on Pregnancy Outcomes and Gestational Weight Gain, Ashton I. D'Souza, Rochester Regional Health; Hala Abdullahi; and Ibrahim Ibrahim

Link

2-2-2026          Rapidly progressive kidney failure in an 82-year-old man with respiratory symptoms, Bernardo Henrique Mendes Correa, Ali Mushtaq, Ali Awada, et al.

Link

2-1-2026          Abstract WP369: Triglyceride-Glucose Index; a Novel Predictor of Stroke and Cardiovascular Events in Patients with Myocardial Infarction: a Systematic Review and Meta-analysis, Abhigan Shrestha, Sulochana Khadka, Srijana Katwal, et al.

Link

2-1-2026          Endoscopic Sphincterotomy Increases the Risk of Pyogenic Liver Abscess: A Retrospective Study Using Real-World Data, Abdellatif Ismail, Bisher Sawaf, Pinghsin Hsieh, et al.

Link

2-1-2026          Implications of the 2025 AHA/ACC high blood pressure guidelines on the initiation and intensification of blood pressure-lowering medications among US adults, Ahmed Sayed, Rochester Regional Health; Eric D. Peterson; and Ann Marie Navar

Link

2-1-2026          Incidence of atrial fibrillation and related events with glucagon-like peptide-1 receptor agonist use in chronic kidney disease, Ninad Khandekar, Rochester Regional Health; D Jadvani; and N Jain